Level Biotechnology Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 116.64 million compared to TWD 162.02 million a year ago. Net income was TWD 10.98 million compared to TWD 18.39 million a year ago. Basic earnings per share from continuing operations was TWD 0.34 compared to TWD 0.57 a year ago. Diluted earnings per share from continuing operations was TWD 0.34 compared to TWD 0.56 a year ago.